Health Sciences considers only articles submitted solely to this journal. The authors should ensure that the submitted manuscript or one with similar content under their authorship has not been previously published or considered for publication elsewhere. Publication of an abstract for conference proceedings will not be considered as a prior publication.
Each author should have participated adequately in the work and authorship credit should be based only on significant contribution to conception and design or acquisition of data or analysis and interpretation of data or drafting or revising the article. On behalf of all coauthors one of the authors can be assigned as a corresponding author, who acts as a primary correspondent with the editorial office during the submission and review process.
Manuscripts reporting data from studies in human or animal should have obtained formal approval from appropriate ethical committees. The details should be explained in the section on methods. Guidelines published by CPCSEA (animal) and ICMR (human) should be followed in experiments.
All manuscripts accepted by the editors of Health Sciences for publication will be the copyright of this journal. The authors should agree to transfer copyright and sign a declaration for this purpose.
The authors will disclose all conflicts of interest, when an author has financial or personal relationship or affiliations that could influence the authors’ decisions, work or manuscript. Acknowledgement section of the manuscript should include this information. All material and financial support received for research should be duly mentioned in the acknowledgement section.
All submitted manuscripts are evaluated by expert reviewers assigned by editors. Manuscripts for publication will be considered on the basis of the following criteria: originality, appropriate and valid study methods, convincing data, significance of results and clarity of writing.
Authors should furnish an authorship form with signed statements on authorship responsibility, originality of work, copyright transfer and conflicts of interest if any as per the format provided.
Manuscripts should be submitted as an attachment to an email to firstname.lastname@example.org
Manuscripts should be composed in English language, and be lucid and concise. Manuscripts should be created in Microsoft Word in Times New Roman style, font size 12, double spaced and formatted for A4 size. Manuscript should be in plain text; sections, parts and headings should be highlighted using bold font.
These articles should include original reports whose conclusions represent a progress in understanding a significant problem in health sciences. These manuscripts can be randomized trials, intervention studies, cohort studies, case control studies, epidemiological studies, experiments conducted in laboratory animals and in vitro studies. Articles can be full length research articles or short communications.
Manuscripts of this kind should be assembled in the following order; title page, abstract and key words, introduction, materials and methods, results, discussion, conclusion, acknowledgement, references, tables and figures. Articles should be typically of 2,500 words excluding abstract and references.
The title page should include title of article, authors’ names and affiliations, name and complete address for correspondence (including telephone number, fax number and email address), and total number of figures and tables. Title of article should be short, specific and informative (not exceeding 150 characters).
Article should include an abstract of not more than 250 words in a new page. Use of acronyms and abbreviations must be limited and defined at first use.
Do not quote reference in the abstract. 3-5 key words should be provided and the words used in the title need not be given as key words.
This section must introduce the subject and briefly explain how research idea is originated. Give a concise background of most recent work in the field. The research aims and objectives should be clear and the purpose of the study should also be mentioned.
The section should provide sufficient information about materials and methods of the study so that the reader can interpret and repeat the experiments if necessary. Complete descriptions of methods already published should be avoided and should explain new additions or variations if any from previously published reports. Details of ethical approval for the study in the case of experiments including human subjects and animals should be provided. Complete name and location of the manufacturer or supplier must be given for all reagents, equipments and devices used. Drugs and chemicals are to be identified using their nonproprietary names or generic names.
Results should be stated briefly without any discussions and conclusions. The results should be expressed in a rational order with suitable indication to tables and figures. The same data in tables and figures should not be described in the text.
Articles that contain statistical testing should mention the name of the statistical test and the ‘n’ for each statistical analysis. Standard error of mean or standard deviation should be used to express variation of data.
This section should deal with the interpretation of results rather than repeating the results. Novel and important observations on the basis of presently available information should be discussed. Author can present new hypotheses or recommendations for future studies. It is also important to discuss the weaknesses or limitations in the study and they must be taken into consideration while making conclusions.
Provide only conclusions of the study directly supported by the results along with its implications, avoiding speculation and over generalization.
All people who have made substantial contributions to the study, but who do not fulfill authorship criteria can be named with their specific contributions in this section. Sources of financial support may also be acknowledged.
Reference should be numbered and ordered sequentially as they appear in the text and are to be cited in the text by superscript number at the end of a sentence after the full stop. Papers which have been submitted and accepted but not yet published may be included in the list of references with indication ‘In press’. Personal communications, unpublished observations and submitted manuscripts are not valid references but can be included in the text. References should be typed according to the examples given below. List all the six authors in a reference when there are six or less; when there are seven or more list first six authors followed by ‘et al.’
Panicker SR, Sreenivas P, Babu MS, Karunagaran D, Kartha CC. Quercetin attenuates Monocyte Chemoattractant Protein-1 gene expression in glucose primed aortic endothelial cells through NF-kappaB and AP-1. Pharmacol Res 2010;62:328-36.
Raj B, Sivadasanpillai H, Kartha CC. Molecular Basis of Pulmonary Hypertension in Left Heart Failure. In: Dhalla NS, Nagano M, Ostadal B (editors). Molecular Defects in Cardiovascular Disease. Springer Science, New York 2011; p. 259-71.